Arkolith/Insider Trading/MAZE/Form 4

Bernstein Harold

President, R&D & CMOMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed Mar 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$736K
Net Open-Market Flow
-$736K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 20, 2026Sell(S)6K$48.20$297K9K
Mar 20, 2026Sell(S)4K$49.32$187K5K
Mar 20, 2026Option exercise(M)15K$10.42$156K15K
Mar 20, 2026Sell(S)5K$50.02$252K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 20, 2026Option exercise(M)15K—$0252K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002050172-26-000017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML